’The proposal to set up a NLSRC by the DBT is a welcome suggestion’
AABLE is pleased to note that the emphasis on developing the S&T skills of the India are being taken seriously and that the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
’Aim to incentivise higher spending in R&D’
The economic and political developments in the Eurozone area and the US have affected the world economy including India. Although…
’Custom duty should be minimised, preferably eliminated’
For drug discovery and development, the scientists in pharma world need access to innovative tools like the latest analytical…
’A special focus on R&D funding is required’
It is critical for the country to improve its macro economic conditions in order to have a healthy industrial growth in near term.…
’Encourage R&D activity on clinical research front’
With a vision to establish India as a global centre for high quality, ethical contract research, ACRO India is continuously…
’GST on drugs must not result in higher tax’
The Government might finalise implementation date of GST and we expect the total tax rate for pharma industry to increase. To…
’We need to sustain significant growth process’
The last year has been a good year both on the domestic and foreign markets front and there is optimism that the industry will…
To poll or not to poll
Milind Sathe, Deputy General Manager-Projects, Unichem Laboratories, submits a qualitative analysis of responses to a recently…
Novartis Board of Directors and Dr Daniel Vasella agree to cancel non-compete agreement
The non-compete provided for an annual payout of up to CHF 12 million for six years, for a maximum total payout to Vasella of CHF…